The Role of Prophylactic Oophorectomy in the Management of Hereditary Breast & Ovarian Cancer Syndrome

QR Code

The Role of Prophylactic Oophorectomy in the Management of Hereditary Breast & Ovarian Cancer Syndrome

None

Saved in:

Bibliographic Details
Main Authors:	Lowery, A.J., Sweeney, K.J.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/35366
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prophylactic oophorectomy is recommended in female patients with pseudomyxoma peritonei of an appendiceal origin
by: Fengxian Fu, et al.
Published: (2025-07-01)

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery
by: L. N. Lyubchenko, et al.
Published: (2015-06-01)

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER
by: S. A. Laptiev, et al.
Published: (2018-06-01)

Hereditary ovarian cancer
by: Kh. B. Kotiv, et al.
Published: (2022-11-01)

Hereditary breast cancer and ovarian cancer: clinical course and treatment
by: V. V. Semiglazov, et al.
Published: (2021-03-01)

HEREDITARY MULTIPLE PRIMARY BREAST AND OVARIAN CANCER (CASE REPORT)
by: Е. V. Panferova, et al.
Published: (2016-02-01)

HEREDITARY BREAST CANCER
by: E. M. Bit-Sava, et al.
Published: (2016-02-01)

HEREDITARY DIFFUSE GASTRIC CANCER: GENETIC ASPECTS AND PROPHYLACTIC TOTAL GASTRECTOMY
by: L. N. Lyubchenko, et al.
Published: (2018-09-01)

Factors influencing decision-making on opportunistic salpingo-oophorectomy for ovarian cancer prevention in women with gastrointestinal cancers undergoing intra-abdominal surgery
by: Jaekyung Bae, et al.
Published: (2025-08-01)

CLINICAL AND MORPHOLOGICAL FEATURES OF HEREDITARY OVARIAN CANCER
by: K. B. Kotiv, et al.
Published: (2017-12-01)

Clinical genome sequencing in patients with hereditary breast and ovarian cancer: Concept, implementation and benefits
by: Dennis Witt, et al.
Published: (2025-08-01)

Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population
by: Mina Darooei, et al.
Published: (2017-02-01)

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer
by: Nisreen Elsayegh, et al.
Published: (2018-06-01)

BREAST AND/OR OVARIAN CANCER AS PART OF FAMILY CANCER SYNDROME
by: L. N. Lyubchenko, et al.
Published: (2014-09-01)

Ethnic aspects of hereditary breast cancer
by: P. A. Gervas, et al.
Published: (2019-04-01)

REPARATION SYSTEM GENES: POPULATION DIFFERENCES IN HEREDITARY OVARIAN AND BREAST CANCER DETERMINED BY NEXT-GENERATION SEQUENCING
by: O. I. Brovkina, et al.
Published: (2017-06-01)

Hereditary Endometrial Carcinoma
by: Saldivar, J. Salvador
Published: (2012)

Chemotherapy-Related Amenorrhea in Breast Cancer: Review of the Main Published Studies, Biomarkers of Ovarian Function and Mechanisms Involved in Ovarian Toxicity
by: Berliere, M., et al.
Published: (2011)

Breast and Ovarian Cancer Treatment: Facing Forward Women's Health Care
by: Herlinger, Alice Laschuk, et al.
Published: (2011)

Multiple Molecular Targets of Antrodia camphorata: A Suitable Candidate for Breast Cancer Chemoprevention
by: Yang, Hsin-Ling, et al.
Published: (2012)

Endometriosis-Associated Ovarian Cancer: The Role of Oxidative Stress
by: Yamashita, Yoriko, et al.
Published: (2012)

The role of retroelements in the development of hereditary tumor syndromes
by: R. N. Mustafin, et al.
Published: (2021-12-01)

Hereditary breast cancer associated with Cowden syndrome-related PTEN mutation with Lhermitte-Duclos disease
by: Fuyo Kimura, et al.
Published: (2017-07-01)

The Role of Molecular Imaging Technologies in Breast Cancer Diagnosis and Management
by: Rosenberg, Anne, et al.
Published: (2012)

DETECTION OF MUTATIONS RELATED TO HEREDITARY CANCER IN RELATIVES OF BREAST CANCER PATIENTS
by: G. A. Paul, et al.
Published: (2017-09-01)

Inflammation and Ovarian Cancer
by: Macciò, Antonio, et al.
Published: (2012)

Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema
by: Sarah Walsh, et al.
Published: (2025-05-01)

Mild Forms of Alport Syndrome: Hereditary Nephropathy in the Absence of Extra-Renal Features
by: Yoon, Han-Seung, et al.
Published: (2011)

Novel Insights Into the Role of Inflammation in Promoting Breast Cancer Development
by: Valdivia-Silva, J., et al.
Published: (2011)

Prophylactic Medical Treatment of Diabetic Retinopathy
by: Kakehashi, Akihiro, et al.
Published: (2012)

The Role of MUC16 Mucin (CA125) in the Pathogenesis of Ovarian Cancer
by: Rancourt, Claudine, et al.
Published: (2012)

Breast reconstruction after prophylactic contralateral mastectomy
by: Raidel Deucher Ribeiro, et al.
Published: (2018-09-01)

Neoadjuvant Chemotherapy in Ovarian Cancer
by: Singh, Jasmeet Chadha, et al.
Published: (2012)

Epidemiology and Etiology of Ovarian Cancer
by: Montes, Ana Fernández, et al.
Published: (2012)

Apoptosis Pathways in Ovarian Cancer
by: Sers, Christine, et al.
Published: (2012)

Electroretinogram in Hereditary Retinal Disorders
by: Gundogan, Fatih Cakir, et al.
Published: (2011)

Hereditary predisposition to kidney cancer: cancer syndromes, multisystemic disorders, and nephropathies
by: G. A. Yanus, et al.
Published: (2023-07-01)

The Impact of Polycystic Ovarian Syndrome on Gestational Diabetes
by: Aust, Stefanie, et al.
Published: (2011)

Hereditary syndromes in pediatric hematooncology
by: Valentina M. Kozlova, et al.
Published: (2023-12-01)

The Role of Fibrin(ogen) in Transendothelial Cell Migration During Breast Cancer Metastasis
by: Simpson-Haidaris, Patricia J., et al.
Published: (2011)